Brief: Star Combo Pharma Ltd Posts HY Revenue From Ordinary Activities $21.1 Mln
Feb 26 (Reuters) - Star Combo Pharma Ltd S66.AX :
* HY REVENUE FROM ORDINARY ACTIVITIES $21.1 MILLION VERSUS
$5.9
MILLION
* HY LOSS ATTRIBUTABLE $1.2 MILLION VERSUS LOSS OF $1.3
MILLION
Source text for Eikon: ID:nASX7nNlQK
Further company coverage: S66.AX
(Reuters.Briefs@thomsonreuters.com)
Recent news on Star Combo Pharma
See all newsBrief: Star Combo Pharma Announces Insurance Claim Settlement Of A$5 Million
Brief: Star Combo Pharma Says Outlook For FY2025 Is Positive
Brief: Star Combo Pharma Says HY Operating Loss Attributable A$4.4 Million
Brief: Star Combo Pharma Posts Q1 Fy23 Revenue Of A$6.55M
Australia's Star Combo Pharma plunges to record low on fire incident